Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thoughts on carcinogenesis testing: the FDA today.

B A Schwetz1

  • 1U.S. Food and Drug Administration, Rockville, Maryland 20857.

Drug Metabolism Reviews
|April 25, 2000
PubMed
Summary

Future cancer prevention relies on epidemiological and animal studies to minimize exposure. New methods may reduce reliance on traditional 2-year bioassays for identifying carcinogens, aiding early cancer detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mercury and health.

The New England journal of medicine·2002
Same author

Remarks of the Acting Principal Deputy Commissioner of Food and Drugs.

Food and drug law journal·2002
Same author

From the Food and Drug Administration.

JAMA·2001
Same author

From the Food and Drug Administration.

JAMA·2001
Same author

From the Food and Drug Administration.

JAMA·2001
Same author

From the Food and Drug Administration.

JAMA·2001

Area of Science:

  • Toxicology
  • Oncology
  • Epidemiology

Background:

  • Cancer prevention strategies are evolving.
  • Traditional methods for identifying chemical carcinogens, like the 2-year bioassay, are being re-evaluated.
  • Minimizing human exposure to carcinogens is a key goal.

Purpose of the Study:

  • To discuss the future of carcinogen identification and risk management.
  • To explore alternative approaches to traditional animal testing.
  • To highlight the importance of understanding modes of action for carcinogen detection and early cancer diagnosis.

Main Methods:

  • Review of current trends in animal testing and research.
  • Discussion of epidemiological and animal study findings.
  • Exploration of alternative markers for carcinogenic potential.

Main Results:

  • Changes in animal testing suggest reduced dependence on 2-year bioassays for initial screening.
  • Understanding the mode of action of chemicals can improve carcinogen identification.
  • New markers may aid in early cancer detection.

Conclusions:

  • Future cancer prevention will integrate epidemiological data, animal studies, and exposure minimization.
  • The 2-year bioassay may shift from a primary screening tool to a confirmatory method.
  • Describing modes of action is crucial for predicting carcinogenic potential and enabling early cancer detection.

Related Experiment Videos